151 related articles for article (PubMed ID: 20155454)
1. Binding of EGF1 domain peptide in coagulation factor VII with tissue factor and its implications for the triggering of coagulation.
Mei H; Hu Y; Wang H; Shi W; Deng J; Guo T
J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):42-7. PubMed ID: 20155454
[TBL] [Abstract][Full Text] [Related]
2. Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII.
Williamson V; Pyke A; Sridhara S; Kelley RF; Blajchman MA; Clarke BJ
J Thromb Haemost; 2005 Jun; 3(6):1250-6. PubMed ID: 15892860
[TBL] [Abstract][Full Text] [Related]
3. [Expression of fusion protein encoding EGFP-EGF1 of rat coagulation factor VII and its binding function].
May H; Hu Y; Zhang YH; Wang HF; Fang J; Guo T; Wei WN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):181-4. PubMed ID: 18315926
[TBL] [Abstract][Full Text] [Related]
4. A tissue factor targeted nanomedical system for thrombi-specific drug delivery.
Shi W; Mei H; Deng J; Chen C; Wang H; Guo T; Zhang B; Li L; Pang Z; Jiang X; Shen S; Hu Y
Biomaterials; 2012 Oct; 33(30):7643-54. PubMed ID: 22819496
[TBL] [Abstract][Full Text] [Related]
5. EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery.
Mei H; Shi W; Pang Z; Wang H; Lu W; Jiang X; Deng J; Guo T; Hu Y
Biomaterials; 2010 Jul; 31(21):5619-26. PubMed ID: 20413154
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
7. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
Thiec F; Cherel G; Christophe OD
J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of cerebral thrombosis by EGFP-EGF1 protein conjugated ferroferric oxide magnetic nanoparticles.
Hu Y; Li Z; Shi W; Yin Y; Mei H; Wang H; Guo T; Deng J; Yan H; Lu X
J Biomater Appl; 2019 Apr; 33(9):1195-1201. PubMed ID: 30646803
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Antitumor Activity of EGFP-EGF1-Conjugated Nanoparticles by a Multitargeting Strategy.
Zhang B; Jiang T; Ling L; Cao Z; Zhao J; Tuo Y; She X; Shen S; Jiang X; Hu Y; Pang Z
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8918-27. PubMed ID: 26890991
[TBL] [Abstract][Full Text] [Related]
11. Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitution in factor IX.
Ndonwi M; Broze GJ; Agah S; Schmidt AE; Bajaj SP
J Biol Chem; 2007 May; 282(21):15632-44. PubMed ID: 17387172
[TBL] [Abstract][Full Text] [Related]
12. A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
Oncotarget; 2017 May; 8(19):32212-32227. PubMed ID: 27793028
[TBL] [Abstract][Full Text] [Related]
13. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
14. Identification of regions of bovine factor VII essential for binding to tissue factor.
Higashi S; Nishimura H; Aita K; Iwanaga S
J Biol Chem; 1994 Jul; 269(29):18891-8. PubMed ID: 8034645
[TBL] [Abstract][Full Text] [Related]
15. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor.
Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ
Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729
[TBL] [Abstract][Full Text] [Related]
16. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
17. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
18. Cells and the activation of factor VII.
Rao LV; Rapaport SI
Haemostasis; 1996; 26 Suppl 1():1-5. PubMed ID: 8904164
[TBL] [Abstract][Full Text] [Related]
19. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
[TBL] [Abstract][Full Text] [Related]
20. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
